|
CCB02
|
CCB02
|
2100864-57-9
|
|
CC-1088
|
化合物 CC-1088
|
467421-06-3
|
|
CCG-100602
|
CCG-100602
|
1207113-88-9
|
|
CCR1 antagonist 9
|
化合物 T10710
|
1220026-26-5
|
|
CCT-251921
|
CCT251921
|
1607837-31-9
|
|
Cdc7-IN-3
|
Cdc7-IN-3
|
1402057-87-7
|
|
CC-3052
|
化合物 T30774
|
216884-02-5
|
|
CCK-B Receptor Antagonist 1
|
168161-71-5
|
168161-71-5
|
|
CCX140-B
|
3-三氟甲基-4-氯-N-[2-[7H-吡咯并[2,3-D]嘧啶-4-羰基]-5-甲基-3-吡啶基]苯磺酰胺
|
1100318-47-5
|
|
CCR4 antagonist 2
|
CCR4 antagonist 2
|
2206788-99-8
|
|
CBP/p300-IN-1
|
Benzoic acid, 3-[[(1-acetyl-5-methoxy-1H-indol-3-yl)carbonyl]amino]-4-fluoro-, 1,1-dimethylethyl ester
|
2443789-32-8
|
|
CBP-aminomethylenevancomycin
|
|
|
|
CCK Octapeptide, non-sulfated acetate
|
化合物CCK OCTAPEPTIDE, NON-SULFATED ACETATE
|
|
|
CCR5 antagonist 1
|
716354-86-8
|
716354-86-8
|
|
CCR1 antagonist 6
|
化合物 T10708
|
2436773-01-0
|
|
CCK (26-30) (sulfated)
|
CCK (26-30) (SULFATED)
|
89911-69-3
|
|
CD161
|
化合物 CD161
|
1627716-22-6
|
|
CDK/HDAC-IN-1
|
化合物 CDK/HDAC-IN-1
|
|
|
CCG-63808
|
ALPHA-[[2-(4-氟苯氧基)-9-甲基-4-氧代-4H-吡啶并[1,2-A]嘧啶-3-基]亞甲基]-2-苯并噻唑乙腈
|
620113-73-7
|
|
CCK-B Receptor Antagonist 2
|
CCK-B RECEPTOR ANTAGONIST 2
|
155412-88-7
|
|
CCR1 antagonist
|
CCR1 antagonist
|
1003566-93-5
|
|
CBP/p300-IN-5
|
P300/CBP-IN-5
|
1889284-33-6
|
|
Cdc7-IN-6
|
Cdc7-IN-6
|
1402057-88-8
|
|
CBP/p300-IN-12
|
|
2738688-57-6
|
|
CCR2-RA
|
4-乙酰基-1-(4-氯-2-氟苯基)-5-環(huán)己基-1,5-二氫-3-羥基-2H-吡咯-2-酮
|
512177-31-0
|
|
CCT020312
|
CCT020312
|
324759-76-4
|
|
C-DIM12
|
C-DIM12
|
178946-89-9
|
|
CBP-iminomethylenevancomycin
|
|
|
|
Cdc7-IN-4
|
Cdc7-IN-4
|
1402059-21-5
|
|
CC-115 hydrochloride
|
1300118-55-1
|
1300118-55-1
|
|
CBR 5884
|
CBR-5884
|
681159-27-3
|
|
CCMI
|
CCMI
|
917837-54-8
|
|
CC-90011 besylate
|
CC-90011
|
2097523-60-7
|
|
CDK1 Inhibitor
|
Cdk1 Inhibitor
|
220749-41-7
|
|
CCG 203769
|
化合物CCG 203769
|
410074-60-1
|
|
CC-99677
|
化合物 CC-99677
|
1887069-10-4
|
|
CBR-470-1
|
化合物 CBR-470-1
|
2416095-06-0
|
|
CCG-222740
|
CCG-222740
|
1922098-69-8
|
|
CD40-TRAF6 inhibitor
|
化合物6877002
|
433249-94-6
|
|
CCR6 inhibitor 1
|
2-Pyridinecarboxamide, 4-[4-[[trans-4-[[5-(trifluoromethyl)-2-pyridinyl]amino]cyclohexyl]sulfonyl]phenyl]-
|
2437547-04-9
|
|
CD38 inhibitor 1
|
CD38 inhibitor
|
1700637-55-3
|
|
CC-115
|
CC-115
|
1228013-15-7
|
|
Cdc7-IN-1
|
CDC7-IN-1 (COMPOUND 13)
|
1402055-25-7
|
|
CD 3254
|
3-[4-Hydroxy-3-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)phenyl]-2-propenoicacid
|
196961-43-0
|
|
CD532 hydrochloride
|
|
2926498-81-7
|
|
CDDO-3-P-Im
|
CPD1589
|
1883650-95-0
|
|
CC0651
|
4,5-二脫氧-5-(3',5'-二氯[1,1'-聯(lián)苯]-4-基)-4-[(2-甲氧基乙酰基)氨基]-L-阿拉伯糖酸
|
1319207-44-7
|
|
CCR2 antagonist 1
|
CCR2 ANTAGONIST 1
|
1683534-96-4
|
|
CCT241736
|
CS-2683
|
1402709-93-6
|
|
CDK/CRK Inhibitor
|
Cdk/Crk Inhibitor
|
784211-09-2
|
|
CBR-470-2
|
CBR-470-2
|
2416095-00-4
|
|
CD73-IN-2
|
化合物 CD73-IN-2
|
|
|
CCG-1423
|
CCG1423
|
285986-88-1
|
|
CC-90001
|
CC90001
|
1403859-14-2
|
|
CC-90002
|
|
2085844-54-6
|
|
CC-671
|
CC-671
|
1618658-88-0
|
|
CC-90003
|
1621999-82-3
|
1621999-82-3
|
|
CDD3505
|
4-NITRO-1-TRITYL-1H-IMIDAZOLE
|
173865-33-3
|
|
CCR2 antagonist 3
|
CCR2 ANTAGONIST 3
|
1380100-86-6
|
|
CCG 2046
|
化合物 CCG-2046
|
13017-69-1
|
|
CCT251545
|
CCT251545
|
1661839-45-7
|
|
Cdc7-IN-5
|
Cdc7-IN-5
|
1402057-86-6
|
|
CC 401 dihydrochloride
|
|
2250025-96-6
|
|
CCT245737(S)
|
5MG
|
1489389-23-2
|
|
CC-17369
|
CC-17369
|
1547162-46-8
|
|
CCT241161
|
化合物CCT241161
|
1163719-91-2
|
|
Cdc7-IN-7
|
Cdc7-IN-7
|
1402059-17-9
|
|
CBS1117
|
化合物CBS1117
|
959245-08-0
|
|
CCG-224406
|
化合物 T30777
|
1870843-22-3
|
|
CD12681
|
化合物 T25216
|
1952239-59-6
|
|
CD73-IN-1
|
2132396-40-6
|
2132396-40-6
|
|
CCG-63802
|
ALPHA-[[9-甲基-2-(3-甲基苯氧基)-4-氧代-4H-吡啶并[1,2-A]嘧啶-3-基]亞甲基]-2-苯并噻唑乙腈
|
620112-78-9
|
|
CCT196969
|
CB93134226
|
1163719-56-9
|
|
CBP-C1-aminomethylenevancomycin
|
|
|
|
CCK (27-33) (non-sulfated)
|
TYR-MET-GLY-TRP-MET-ASP-PHE-NH2
|
47910-79-2
|
|
CCR7 Ligand 1
|
Benzamide, 3-[[4-[[(1R)-2,2-dimethyl-1-(5-methyl-2-furanyl)propyl]amino]-1,1-dioxido-1,2,5-thiadiazol-3-yl]amino]-2-hydroxy-N,N,6-trimethyl-
|
681514-83-0
|
|
CC-618
|
化合物CC618
|
1680204-90-3
|
|
CDDO-2-P-Im
|
CPD1599
|
1883650-96-1
|
|
CBP/p300-IN-8
|
|
2304416-91-7
|
|
CDDO-DhTFEA
|
RTA dh404
|
1191265-33-4
|
|
CD235
|
CD235
|
1627716-57-7
|
|
CD 2665
|
4-[7-(1-ADAMANTYL)-6-(2-METHOXYETHOXYMETHOXY)NAPHTHALEN-2-YL]BENZOIC ACID
|
170355-78-9
|
|
CCTA-1523
|
化合物CCTA-1523
|
1616271-41-0
|
|
CCT128930 hydrochloride
|
4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine hydrochloride
|
2453324-32-6
|
|
CDDD3602
|
113932-41-5
|
113932-41-5
|
|
CCR4 antagonist 3
|
CCR4 ANTAGONIST 3
|
2174938-70-4
|
|
CDDU-Me
|
CDDU-Me
|
1616932-17-2
|
|
CD73-IN-5
|
CD73-IN-5
|
2412019-99-7
|
|
CBP/p300-IN-14
|
CBP/P300-IN-14
|
2725036-10-0
|
|
CCR4 antagonist 3 hydrochloride
|
|
2174938-71-5
|
|
CD1530
|
CD1530
|
107430-66-0
|
|
CCK (26-31) (sulfated)
|
AC-ASP-TYR(SO3H)-MET-GLY-TRP-MET-NH2
|
89911-65-9
|
|
c-di-UMP
|
|
73120-97-5
|
|
CD73-IN-4
|
化合物CD73-IN-4
|
2216764-29-1
|
|
CDDO-TFEA
|
CDDO-TFEA
|
932730-52-4
|
|
CCK-A receptor inhibitor 1
|
137004-80-9
|
137004-80-9
|
|
CBP/EP300-IN-2
|
CBP/EP300-IN-2
|
2158265-96-2
|
|
CCR1 antagonist 7
|
化合物 T10709
|
2446154-74-9
|
|
CC-12074
|
化合物 T30770
|
460741-57-5
|
|
CCF0058981
|
化合物CCF0058981
|
2708934-53-4
|